MEETING AGENDA

Symposium for Life Science Innovation and Development in Philadelphia
September 12, 2022
Philly Builds Bio symposium
Symposium for life science innovation and development in Philadelphia

AGENDA

save the date - philly builds bio 2nd annual symposium in philadelphia 2023

The Philly Builds Bio+ Annual Symposium plays a crucial role in strengthening the city's position as a thriving life science hub

The Inaugural Symposium in 2022 was sold out and attended by more than 300 registrants. Over 40 speakers participated across the entire ecosystem, offering 3 keynotes and 7 panels, covering the science driving innovation and commercialization, venture capital investment, company formation and life sciences company development, among other topics.

By bringing together key stakeholders, facilitating knowledge exchange, and supporting the creation of initiatives like Philly Builds Bio+, the Symposium contributes to the continued growth and success of the life science industry in Philadelphia.

Agenda

8:00 – 8:30    REGISTRATION AND CONTINENTAL BREAKFAST

8:30 – 8:45    WELCOME

  • Nancy J Kelley, JD/ MPP, President & CEO, Nancy J Kelley + Associates and Founding Member, Builds BIO+ (Confirmed)
  • Mitchel W. Simpler, Managing Partner Emeritus, JB&B, Founding Member, Builds BIO+ (Confirmed)

8:45 – 9:00    OPENING KEYNOTE: FOSTERING INNOVATION, SUPPORTING TRANSFORMATIONAL ECONOMIC DEVELOPMENT AND CREATING OPPORTUNITY IN PENNSYLVANIA 

The State of Pennsylvania aims to be a leader in economic growth, job creation, and innovation by connecting businesses, the workforce, PA’s world-class universities and research institutions, and the public sector to spur economic development, particularly in communities that have too often been left behind. By helping businesses that are already in Pennsylvania, encouraging new ones to move to Pennsylvania, and investing in the workforce, the Governor’s Office of Transformation and Opportunity aims to create real opportunity and build an economy that works for everyone.

  • The Honorable Josh Shapiro, Governor of Pennsylvania (Invited)
  • Ben Kirshner, Chief Transformation and Opportunity Officer, Pennsylvania Office of Transformation and Opportunity (Invited)

9:00 – 9:40    THE SCIENCE DRIVING INNOVATION AND COMMERCIALIZATION IN PHILADELPHIA’S RESEARCH INSTITUTIONS

This session will include a panel of scientists from Philly institutions, moderated by a leading scientist, and will explore the recent and next generation of technologies that are emerging from Philly institutions, driven by increasing NIH funding levels to Philadelphia institutions. The panel will also explore how science can differentiate Philadelphia from other major life science clusters such as Boston, San Francisco and the Greater NYC Metro area.

Moderator:  

Todd J. Kilbaugh, MD, Endowed Chair of Translational Science and Innovation, The Children’s Hospital of Philadelphia (CHOP) and Medical Director, EMCO Center at CHOP

9:40 – 10:20    THE INTERSECTION OF SCIENCE AND TECHNOLOGY ACCELERATING INNOVATION AND BREAKTHROUGHS

This session will include a panel of innovators focusing on new technologies driving innovation and commercialization.  The panels would include scientists from Greater Philly institutions and will explore the recent and next generation of tools, technologies and techniques that are emerging from institutions across the Greater Philly area.  Suggestions include:

Moderator:
  • Kathleen Brunner, President, Acumen Analytics
Suggested Speakers:
  • Jeet Sarkar, Vice President and Head of IT, Center for Breakthrough Medicine
  • Michael Montello, Senior Vice President, R&D, Digital Tech, GSK
  • Google Ventures 

10:20 – 10:40   BREAK

10:40 – 11:20   COMMERCIALIZING INNOVATIONS INTO PRODUCTS: THE LIFE SCIENCE COMPANY PIPELINE

This session will feature three or four mature life science companies, all of whom have received venture backing or are publicly traded. Speakers will discuss the unique life science real estate requirements that stem from the unique science they are pursuing or products developed.  The current regulatory and financial challenges in the life sciences market and the competitive pressures from surrounding life science clusters will also be discussed.

Suggested Moderator:

Melina Blees, Site Director, BioLabs Philadelphia

Suggested Speakers:
  • Sean Hemingway, COO, IMVAX
  • Gwen Binder, President, Science and Technology, Cabaletta Bio
  • Kenneth Locke, Carisma Therapeutics, VP, Manufacturing and Supply Chain
  • Doug Carr, Century Therapeutics, Senior Vice President and Head of Finance

11:20 – 11:35   KEYNOTE: PHARMA EXECUTIVE (Steve Eberling)

11:35 – 12:15   THE ART OF PHARMA AND BIOTECH DEAL MAKING

This panel will feature a group of pharma executives discussing the currently environment  in the pharma market.  How is the pharma and biotech deal-making environment evolving? What data and indications are Pharma looking for? How can the Biotechs best prepare? Is global M&A picking up traction? What is your preferred way to engage and at what time? Are there preferences between technology and therapeutics? Are platforms the future?

Moderator: 
  • Jennifer Manning, MPA, SVP, Global Strategic Partnerships, Center for Breakthrough Medicines
 Suggested Speakers:
  • Sherrie Glass,Senior Vice President, Enterprise Strategy, Bristol Myers Squibb
  • Jens Bitsch-Norhave, Vice President, Transactions and Innovation Partnering, Johnson & Johnson Innovation
  • Nuray Yurt,Business Engagement and Activation Lead, Merck Human Health
  • Brad Bailey,Senior Vice President and General Manager, US, Genmab
  • William Pao,Chief Development Officer, Executive Vice President, Pfizer
  • Leonard Schleifer,Founder and CEO, Regeneron
  • Mohit Manrao,SVP, Head of US Oncology, AstraZeneca

12:15 – 1:00    LUCH

1:00 – 1:15    PATIENT KEYNOTE

  • Vince Papale, Eagles (Movie) (Steve Eberling)
  • Tom Whitehead (Steve Eberling, Jennifer Manning)

1:15 – 1:45    THE PATIENT’S PERSPECTIVE

This panel will focus on the patient’s perspective, championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems and society while acknowledging the challenges of access to new therapies and equitable participation.

Suggested Speakers:
  • Michael Lemiky, Vice President, Science and Industry Affairs, Alliance for Regenerative Medicine (Jennifer Manning, Kathleen Brunner)
  • George McMillan, Executive Vice President and Chief Commercial Officer, ICON plc (Jennifer Manning)

1:45 – 2:15    HOUSING LIFE SCIENCE INNOVATION: THE NAVY YARD PHILADELPHIA 

The Navy Yard is one of the most successful redevelopment projects in US history and today is a thriving riverfront community in South Philadelphia, with more than 15k people + 150 companies + 20 acres of parks, dining options, public art, and a variety of outdoor events.  Today, the 2022 Navy Yard Plan charts the next 20 years of equitable growth at the Navy Yard, expecting to deliver an estimated 12,000 new jobs, 8.9 million square feet of new mixed-use development, and $6B of new investment.  Big or small, global or startup, the Navy Yard is a community of people and companies working alongside each other in an environment that is flexible, customizable, and often unconventional.

This panel will showcase the Navy Yard and its most important tenants.

Moderator:

Nelson Way, Director Leasing and Development

2:15 – 2:30    KEYNOTE: WORKFORCE DEVELOPMENT/ ENSURING SOCIAL EQUITY IN LIFE SCIENCES 

Mosaic Development Partners JV, Mosaic Development Partners JV (Mosaic) is a Philadelphia based, minority certified commercial real estate development company founded in 2008. Mosaic primarily focuses on ground up development and adaptive reuse of land and buildings in marginalized urban centers. The company has successfully used viable and innovative financial and construction methods to help stabilize and grow neighborhoods. 

2:30 – 3:00    THINKUBATOR @ CU – CHEYNEY UNIVERSITY OF PENNSYLVANIA

Founded in 1837, Cheyney University is not only the nation’s 1st historically black university; it is one of Pennsylvania’s 1st universities. Twenty-four years before
the start of the Civil War, the first American institution to provide education for people of African descent to prepare them for skilled jobs and teaching was established in Philadelphia. The Institute for Colored Youth would later be renamed Cheyney University of Pennsylvania.

Today Cheyney University is engaging a more diverse workforce in the life sciences by launching a new initiative called the ThinkUbator.  The ThinkUbator carries Cheyney’s spirit of academic innovation infused with a message of deep social justice. The ThinkUbator offers biologics, cell, and gene therapy companies the opportunity to practically pursue their science in a campus setting by leasing the process development and wet lab space in an incubator building dedicated to private enterprise on campus. It provides opportunities to new enterprising businesses and students of color across the university. 

MODERATOR:
  • Eric Hacherl, Chief Operating Officer, Kyttaro Therapeutics
Suggested Speakers:
  • The Wistar Institute
  • Integrated Project Services
  • The Philadelphia Research Consortium
  • West Philadelophia Skills Initiative
  • Life Science Cares Philadelphia
  • West Philadelphia Skills Center

3:00 - 4:00      RECEPTION

8:00am – 8:30am: REGISTRATION & CONTINENTAL BREAKFAST

8:30am – 8:45am: WELCOME

  • Nancy J Kelley, JD/ MPP
    Nancy J Kelley + Associates, President & CEO
    Builds Bio+, Founding Member
  • Mitchel W. Simpler
    JB&B, Partner Emeritus
    Builds Bio+, Founding Member

8:45am – 9:00am: OPENING KEYNOTE
Fostering Transformational Discovery During a Time of Immense Need and Great Change

  • Jonathan A. Epstein, MD
    Penn Medicine, Executive Vice Dean and Chief Scientific Officer

9:00am – 9:40am
The Science Driving Innovation and Commercialization in Philadelphia's Research Institutions

This session will include a panel of scientists from Philly institutions, moderated by a leading scientist, and will explore the recent and next generation of technologies that are emerging from Philly institutions, driven by increasing NIH funding levels to Philadelphia institutions. The panel will also explore how science can differentiate Philadelphia from other major life science clusters such as Boston, San Francisco and the Greater NYC Metro area. 

Moderator:

  • Todd J. Kilbaugh, MD
    The Children’s Hospital of Philadelphia
    Endowed Chair of Translational Science and Innovation

Confirmed Speakers:

  • William Peranteu, MD
    Children’s Hospital of Philadelphia
    Attending Fetal Surgeon, Division of General, Thoracic and Fetal Surgery
  • Misun Hwang, MD, MS
    Children’s Hospital of Philadelphia
    Radiologist, Director of Neonatal Imaging
  • John Karanicolas
    Fox Chase Cancer Center, Professor of Molecular Therapies,
    School of Pharmacy’s Moulder Center for Drug Discovery Research, Director

9:40am – 10:20am
The Intersection of Science and Technology Accelerating Innovation and Breakthroughs

This session will include a panel of innovators focusing on new technologies driving innovation and commercialization. The panels would include technology experts and will explore the recent and next generation of tools, technologies and techniques that are emerging from institutions across the Greater Philly area.

Moderator:

  • Kathleen Brunner
    Acumen Analytics    , President

Confirmed Speakers:

  • Eric Heil
    Medical Excellence Capital, Managing Partner
  • Sima Singadia Kulkarni
    Duane Morris LLP, Special Counsel: Patents, Trademarks, Copyrights, Licensing
  • Sangeeta Bardhan Cook, PhD, MBA
    Fox Chase Cancer Center, Chief Innovation Officer
    Temple University Health System, SVP of Strategy and Business Development
  • Ben Dibling
    Penn Center for Innovation, Deputy Managing Director
  • Andrei Georgescu
    Vivodyne, Penn Spinout, CEO

10:20am – 10:40am: BREAK

10:40am – 11:20am
The Philly Life Science Continuum: Fueling the Advancement of Science

This panel will focus on the different elements necessary for the growth and development of life sciences, beginning with institutional research to fuel discovery, incubators/accelerators to house startups, venture capital to make them grow and real estate to furnish housing at every stage of a company’s life cycle.

Moderator:

  • Louis P. Kassa, III, MPA
    Baruch S. Blumberg Institute and PA Biotechnology Center
    Chief Executive Officer

Confirmed Speakers:

  • Matthew Burkhardt
    B+labs    , Director
  • Lorenzo Pellegrini, PhD
    Hatch Biofund    , Managing Partner
  • Jeffrey DeVuono,
    Life Sciences, Brandywine Realty Trust
    Executive Vice President, Senior Managing Director
  • Jesse Johnson
    Serna BIO, Chief Technology Officer

11:20am – 11:35am
The Patient Perspective: The Peter Powerhouse Foundation

The Peter Powerhouse Foundation was formed to improve the lives of children that are currently fighting childhood cancer by providing donations to pediatric cancer treatment facilities, and contributing financial support to researchers to improve the lives of childhood cancer survivors. http://www.peterpowerhouse.org

Hear from Peter Zucca, first diagnosed with cancer at the age of 10 months and now 20 years old, tell his story and how the Peter Powerhouse Foundation was born. Jennifer Ball, current Executive Director of the Foundation, will also share how she came to be involved in the Foundation, her family’s story and the stories of other families the Foundation is serving.

Confirmed Speakers:

  • Jennifer Bell
    Peter Powerhouse Foundation    , Executive Director
  • Peter Zucca
    Peter Powerhouse Foundation    , Founder

11:35am – 12:15am:
Commercializing Innovations into Products: The Life Science Company Pipeline

This session will feature three or four mature life science companies, all of whom have received venture backing or are publicly traded. Speakers will discuss the unique life science real estate requirements that stem from the unique science they are pursuing or products developed. The current regulatory and financial challenges in the life sciences market and the competitive pressures from surrounding life science clusters will also be discussed.

Moderator:

  • Melina Blees
    BioLabs Philadelphia    , Site Director

Confirmed Speakers:

  • Tracy Brala
    University City Science Center    , Senior Vice President, Strategy & Partnerships
  • Kenneth Locke
    Carisma Therapeutics    , VP, Manufacturing and Supply Chain
  • Douglas Carr
    Century Therapeutics, Senior Vice President and Head of Finance
  • Mark Laurenzi
    Aro Biotherapeutics Company    , Chief Administrative Officer
  • Jennifer Griffin
    Mission Biocapital    , Partner, Strategy & Investor RelationsPartner, Strategy & Investor Relations
  • Eric Hacherl
    Kyttaro Therapeutics, Chief Operating Officer

12:15pm – 1:00pm: LUNCH

1:00pm – 1:15pm: PHARMA KEYNOTE
The Promise of Future Collaboration in the Philadelphia Ecosystem

  • Michael Flaschen
    Daiichi Sankyo, SVP, Global External Innovation

1:15pm – 1:45pm:
The Art of Pharma and Biotech Deal Making

This panel will feature a group of pharma and biotech executives discussing the current environment in the pharma market. How is the pharma and biotech deal-making environment evolving? What data and indications are Pharma looking for? How can the Biotechs best prepare? Is global M&A picking up traction? What is your preferred way to engage and at what time? Are there preferences between technology and therapeutics? Are platforms the future?

Moderator:

  • Jennifer Manning, MPA
    Kyttaro Therapeutics
    Cell and Gene Therapy Commercial Executive, Strategic Advisor

Confirmed Speakers:

  • Colin Moran
    Johnson & Johnson Innovation Center, Senior Director, Transactions, Discovery Sciences, Global Innovation Partnering Lead
  • Elizabeth White
    Entrepreneur and Former Pharma Executive
  • Joseph W LaBarge
    Apertura Gene Therapy, Chief Executive Officer
  • Shivaranjani Sridharan
    Bayer, Senior Director, Business Development & Licensing

1:45pm – 2:15pm
Housing Life Science Innovation: The Navy Yard Philadelphia

The Navy Yard is one of the most successful redevelopment projects in US history and today is a thriving riverfront community in South Philadelphia, with more than 15k people + 150 companies + 20 acres of parks, dining options, public art, and a variety of outdoor events. Today, the 2022 Navy Yard Plan charts the next 20 years of equitable growth at the Navy Yard, expecting to deliver an estimated 12,000 new jobs, 8.9 million square feet of new mixed-use development, and $6B of new investment. Big or small, global or startup, the Navy Yard is a community of people and companies working alongside each other in an environment that is flexible, customizable, and often unconventional.

This panel will showcase several of the Navy Yard’s leading edge life science and biotech companies.

Moderator:

  • Nelson Way
    Ensemble    , Director Leasing and Development

Confirmed Speakers/Projects:

  • Ben Pascal
    Invisible Sentinel, Co-Founder and Chief Business Officer
  • John Lunger
    Adaptimmune Therapeutics plc, Chief Patient Supply Officer
  • Sumit Verma
    Iovance Biotherapeutics, Senior Vice President, Global Strategic Manufacturing
  • David Chang
    WuXi App Tech     (Advanced Therapies Group), President and Chief Technology Officer

2:15pm – 2:30pm: KEYNOTE
Workforce Development: Ensuring Economic Opportunity in Life Science

  • Tia Lyles-Williams, MS, MRSc
    Goffman Bougard, Chief Executive Officer
    LucasPye BIO, Founder & CEO
    HelaPlex, Founder & CEO

2:30pm – 3:00pm
Workforce Development: Ensuring Social Equity in Life Sciences

Philadelphia's life sciences industry is experiencing remarkable growth and expansion, but a key factor to maintaining this preeminence is a skilled and well-prepared workforce. Workforce solutions are being developed on multiple fronts in and around Philadelphia. We've gathered a diverse set of success stories that highlight the achievements in our area and examine how other biotech hubs have tackled similar issues. Through the lens of lessons learned, we'll share these success stories and discuss the broader context of where we need to go in the region.

Moderator:

  • John Balchunas
    National Institute for Innovation in Manufacturing Biopharmaceuticals, Workforce Director

Confirmed Speakers:

  • Tom Piombino
    Integrated Project Services, Managing Director, Americas
  • David Zuzga
    The Wistar Institute    , Associate Dean of Biomedical Studies
  • Vanessa Atkins
    Cheyney University, Executive Director of Strategy Partnerships and Career Pathways, Division of Social Equity
  • Phil Brooks
    University City Science Center, Director of STEM Workforce Partnerships

3:00pm – 4:00pm: RECEPTION

Preliminary Agenda

8:00 – 8:30    REGISTRATION AND CONTINENTAL BREAKFAST

8:30 – 8:45    WELCOME

  • Nancy J Kelley, JD/ MPP, President & CEO, Nancy J Kelley + Associates and Founding Member, Builds BIO+ (Confirmed)
  • Mitchel W. Simpler, Managing Partner Emeritus, JB&B, Founding Member, Builds BIO+ (Confirmed)

8:45 – 9:00    OPENING KEYNOTE: FOSTERING INNOVATION, SUPPORTING TRANSFORMATIONAL ECONOMIC DEVELOPMENT AND CREATING OPPORTUNITY IN PENNSYLVANIA 

The State of Pennsylvania aims to be a leader in economic growth, job creation, and innovation by connecting businesses, the workforce, PA’s world-class universities and research institutions, and the public sector to spur economic development, particularly in communities that have too often been left behind. By helping businesses that are already in Pennsylvania, encouraging new ones to move to Pennsylvania, and investing in the workforce, the Governor’s Office of Transformation and Opportunity aims to create real opportunity and build an economy that works for everyone.

  • The Honorable Josh Shapiro, Governor of Pennsylvania (Invited)
  • Ben Kirshner, Chief Transformation and Opportunity Officer, Pennsylvania Office of Transformation and Opportunity (Invited)

9:00 – 9:40    THE SCIENCE DRIVING INNOVATION AND COMMERCIALIZATION IN PHILADELPHIA’S RESEARCH INSTITUTIONS

This session will include a panel of scientists from Philly institutions, moderated by a leading scientist, and will explore the recent and next generation of technologies that are emerging from Philly institutions, driven by increasing NIH funding levels to Philadelphia institutions. The panel will also explore how science can differentiate Philadelphia from other major life science clusters such as Boston, San Francisco and the Greater NYC Metro area.

Moderator:  

Todd J. Kilbaugh, MD, Endowed Chair of Translational Science and Innovation, The Children’s Hospital of Philadelphia (CHOP) and Medical Director, EMCO Center at CHOP

9:40 – 10:20    THE INTERSECTION OF SCIENCE AND TECHNOLOGY ACCELERATING INNOVATION AND BREAKTHROUGHS

This session will include a panel of innovators focusing on new technologies driving innovation and commercialization.  The panels would include scientists from Greater Philly institutions and will explore the recent and next generation of tools, technologies and techniques that are emerging from institutions across the Greater Philly area.  Suggestions include:

Moderator:
  • Kathleen Brunner, President, Acumen Analytics
Suggested Speakers:
  • Jeet Sarkar, Vice President and Head of IT, Center for Breakthrough Medicine
  • Michael Montello, Senior Vice President, R&D, Digital Tech, GSK
  • Google Ventures 

10:20 – 10:40   BREAK

10:40 – 11:20   COMMERCIALIZING INNOVATIONS INTO PRODUCTS: THE LIFE SCIENCE COMPANY PIPELINE

This session will feature three or four mature life science companies, all of whom have received venture backing or are publicly traded. Speakers will discuss the unique life science real estate requirements that stem from the unique science they are pursuing or products developed.  The current regulatory and financial challenges in the life sciences market and the competitive pressures from surrounding life science clusters will also be discussed.

Suggested Moderator:

Melina Blees, Site Director, BioLabs Philadelphia

Suggested Speakers:
  • Sean Hemingway, COO, IMVAX
  • Gwen Binder, President, Science and Technology, Cabaletta Bio
  • Kenneth Locke, Carisma Therapeutics, VP, Manufacturing and Supply Chain
  • Doug Carr, Century Therapeutics, Senior Vice President and Head of Finance

11:20 – 11:35   KEYNOTE: PHARMA EXECUTIVE (Steve Eberling)

11:35 – 12:15   THE ART OF PHARMA AND BIOTECH DEAL MAKING

This panel will feature a group of pharma executives discussing the currently environment  in the pharma market.  How is the pharma and biotech deal-making environment evolving? What data and indications are Pharma looking for? How can the Biotechs best prepare? Is global M&A picking up traction? What is your preferred way to engage and at what time? Are there preferences between technology and therapeutics? Are platforms the future?

Moderator: 
  • Jennifer Manning, MPA, SVP, Global Strategic Partnerships, Center for Breakthrough Medicines
 Suggested Speakers:
  • Sherrie Glass,Senior Vice President, Enterprise Strategy, Bristol Myers Squibb
  • Jens Bitsch-Norhave, Vice President, Transactions and Innovation Partnering, Johnson & Johnson Innovation
  • Nuray Yurt,Business Engagement and Activation Lead, Merck Human Health
  • Brad Bailey,Senior Vice President and General Manager, US, Genmab
  • William Pao,Chief Development Officer, Executive Vice President, Pfizer
  • Leonard Schleifer,Founder and CEO, Regeneron
  • Mohit Manrao,SVP, Head of US Oncology, AstraZeneca

12:15 – 1:00    LUCH

1:00 – 1:15    PATIENT KEYNOTE

  • Vince Papale, Eagles (Movie) (Steve Eberling)
  • Tom Whitehead (Steve Eberling, Jennifer Manning)

1:15 – 1:45    THE PATIENT’S PERSPECTIVE

This panel will focus on the patient’s perspective, championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems and society while acknowledging the challenges of access to new therapies and equitable participation.

Suggested Speakers:
  • Michael Lemiky, Vice President, Science and Industry Affairs, Alliance for Regenerative Medicine (Jennifer Manning, Kathleen Brunner)
  • George McMillan, Executive Vice President and Chief Commercial Officer, ICON plc (Jennifer Manning)

1:45 – 2:15    HOUSING LIFE SCIENCE INNOVATION: THE NAVY YARD PHILADELPHIA 

The Navy Yard is one of the most successful redevelopment projects in US history and today is a thriving riverfront community in South Philadelphia, with more than 15k people + 150 companies + 20 acres of parks, dining options, public art, and a variety of outdoor events.  Today, the 2022 Navy Yard Plan charts the next 20 years of equitable growth at the Navy Yard, expecting to deliver an estimated 12,000 new jobs, 8.9 million square feet of new mixed-use development, and $6B of new investment.  Big or small, global or startup, the Navy Yard is a community of people and companies working alongside each other in an environment that is flexible, customizable, and often unconventional.

This panel will showcase the Navy Yard and its most important tenants.

Moderator:

Nelson Way, Director Leasing and Development

2:15 – 2:30    KEYNOTE: WORKFORCE DEVELOPMENT/ ENSURING SOCIAL EQUITY IN LIFE SCIENCES 

Mosaic Development Partners JV, Mosaic Development Partners JV (Mosaic) is a Philadelphia based, minority certified commercial real estate development company founded in 2008. Mosaic primarily focuses on ground up development and adaptive reuse of land and buildings in marginalized urban centers. The company has successfully used viable and innovative financial and construction methods to help stabilize and grow neighborhoods. 

2:30 – 3:00    THINKUBATOR @ CU – CHEYNEY UNIVERSITY OF PENNSYLVANIA

Founded in 1837, Cheyney University is not only the nation’s 1st historically black university; it is one of Pennsylvania’s 1st universities. Twenty-four years before
the start of the Civil War, the first American institution to provide education for people of African descent to prepare them for skilled jobs and teaching was established in Philadelphia. The Institute for Colored Youth would later be renamed Cheyney University of Pennsylvania.

Today Cheyney University is engaging a more diverse workforce in the life sciences by launching a new initiative called the ThinkUbator.  The ThinkUbator carries Cheyney’s spirit of academic innovation infused with a message of deep social justice. The ThinkUbator offers biologics, cell, and gene therapy companies the opportunity to practically pursue their science in a campus setting by leasing the process development and wet lab space in an incubator building dedicated to private enterprise on campus. It provides opportunities to new enterprising businesses and students of color across the university. 

MODERATOR:
  • Eric Hacherl, Chief Operating Officer, Kyttaro Therapeutics
Suggested Speakers:
  • The Wistar Institute
  • Integrated Project Services
  • The Philadelphia Research Consortium
  • West Philadelophia Skills Initiative
  • Life Science Cares Philadelphia
  • West Philadelphia Skills Center

3:00 - 4:00      RECEPTION

Opening Keynote: FOSTERING INNOVATION, SUPPORTING TRANSFORMATIONAL ECONOMIC DEVELOPMENT AND CREATING OPPORTUNITY IN PENNSYLVANIA

The State of Pennsylvania aims to be a leader in economic growth, job creation, and innovation by connecting businesses, the workforce, PA’s world-class universities and research institutions, and the public sector to spur economic development, particularly in communities that have too often been left behind. By helping businesses that are already in Pennsylvania, encouraging new ones to move to Pennsylvania, and investing in the workforce, the Governor’s Office of Transformation and Opportunity aims to create real opportunity and build an economy that works for everyone.

Session 1: THE SCIENCE DRIVING INNOVATION AND COMMERCIALIZATION IN PHILADELPHIA’S RESEARCH INSTITUTIONS

This session will include a panel of scientists from Philly institutions, moderated by a leading scientist, and will explore the recent and next generation of technologies that are emerging from Philly institutions, driven by increasing NIH funding levels to Philadelphia institutions. The panel will also explore how science can differentiate Philadelphia from other major life science clusters such as Boston, San Francisco and the Greater NYC Metro area.

Session 2: THE PHILLY LIFE SCIENCE CONTINUUM: FUELING THE ADVANCEMENT OF SCIENCE

This session will include a panel of innovators focusing on new technologies driving innovation and commercialization.  The panels would include scientists from Greater Philly institutions and will explore the recent and next generation of tools, technologies and techniques that are emerging from institutions across the Greater Philly area.

Keynote: PATIENT KEYNOTE

Session 3: COMMERCIALIZING INNOVATIONS INTO PRODUCTS: THE LIFE SCIENCE COMPANY PIPELINE

This session will feature three or four mature life science companies, all of whom have received venture backing or are publicly traded. Speakers will discuss the unique life science real estate requirements that stem from the unique science they are pursuing, or products developed.  The current regulatory and financial challenges in the life sciences market and the competitive pressures from surrounding life science clusters will also be discussed.

Keynote: PHARMA EXECUTIVE

Session 4: THE ART OF PHARMA AND BIOTECH DEAL MAKING

This panel will feature a group of pharma executives discussing the currently environment  in the pharma market.  How is the pharma and biotech deal-making environment evolving? What data and indications are Pharma looking for? How can the Biotechs best prepare? Is global M&A picking up traction? What is your preferred way to engage and at what time? Are there preferences between technology and therapeutics? Are platforms the future?

Session 5: HOUSING LIFE SCIENCE INNOVATION: THE NAVY YARD PHILADELPHIA

The Navy Yard is one of the most successful redevelopment projects in US history and today is a thriving riverfront community in South Philadelphia, with more than 15k people + 150 companies + 20 acres of parks, dining options, public art, and a variety of outdoor events. Today, the 2022 Navy Yard Plan charts the next 20 years of equitable growth at the Navy Yard, expecting to deliver an estimated 12,000 new jobs, 8.9 million square feet of new mixed-use development, and $6B of new investment.  Big or small, global or startup, the Navy Yard is a community of people and companies working alongside each other in an environment that is flexible, customizable, and often unconventional.

This panel will showcase several of the Navy Yard’s leading edge life science and biotech companies.

Keynote: WORKFORCE DEVELOPMENT/ ENSURING SOCIAL EQUITY IN LIFE SCIENCES

Session 6: WORKFORCE DEVELOPMENT/ ENSURING SOCIAL EQUITY IN LIFE SCIENCES

Philadelphia's life sciences industry is experiencing remarkable growth and expansion, but a key factor to maintaining this preeminence is a skilled and well-prepared workforce. Workforce solutions are being developed on multiple fronts in and around Philadelphia. We've gathered a diverse set of success stories that highlight the achievements in our area and examine how other biotech hubs have tackled similar issues. Through the lens of lessons learned, we'll share these success stories and discuss the broader context of where we need to go in the region.

Image

2nd Annual Symposium for Life Science Innovation and Development

September 12, 2023
The Union League of Philadelphia
140 S Broad St, Philadelphia
Image
REGISTER NOW
Image
Image
Image

Gold Sponsors

Image
Image
Image
Image

Breakfast and Lunch Co-Sponsors

Image
Meyer Architects Logo
Image
Image

Institutional Sponsors

B.Labs
Image
Image

Lanyard Sponsor

Image

Association Partners

Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Image
Ben Franklin Technology PArtners - Southeastern Pennsylvania
Image
Image